...after disclosing a clinical hold on its Phase I study of CAR T cell therapy P-PSMA-101... ...is marketed in Japan for chronic constipation, did meet the Phase II trial’s primary endpoint. TARGETSPSMA (FOLH1; GCPII... ...membrane antigenSLC10A2 (ASBT; IBAT) - Solute carrier family 10 sodium-dependent bile acid transporter member 2
...in Science Translational Medicine that the bispecifics could boost anti-PD-1 efficacy. Bispecifics against CD28 and PSMA... ...growth factor receptor JAK-2 - Janus kinase-2 PARP - poly(ADP-ribose) polymerase PSMA (FOLH1) (GCPII) - Prostate-specific membrane antigen... ...member
Regeneron Pharmaceuticals Inc.
Dana-Farber Cancer Institute
National Institute on Aging
Broad Institute of MIT and Harvard
Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
...III testing for PSMA-positive metastatic CRPC due to read out in 2020. Endocyte had bought 177Lu-PSMA-617... ...types.” The company’s pipeline of Targeted Thorium Conjugates (TTC) includes three Phase I agents targeting PSMA... ...Targets HER2 (EGFR2; ErbB2; neu) - Epidermal growth factor receptor 2 PSMA (FOLH1; GCPII) - Prostate-specific membrane antigen...